Evaluation of Mer and Axl Expression in Acute Myeloid Leukemia Patient Samples
- To evaluate Mer and Axl expression in samples from pediatric patients with acute
myeloid leukemia (AML).
- To determine if abnormal expression of Mer and Axl is associated with poor clinical
characteristics (e.g., induction failure or relapse) of AML in these patients.
OUTLINE: This is a multicenter study.
Archived samples from pediatric patients with acute myeloid leukemia are analyzed for Mer
and Axl expression by flow cytometry and western blot assays.
Expression of Mer and Axl
Kristen M. Eisenman, MD
University of Colorado, Denver
United States: Federal Government